Avadel Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 03/18/2024
Avadel Pharmaceuticals Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Avadel Pharmaceuticals, the average price target is $22.00, with a high estimate of $29.00 and a low estimate of $19.00. That is a potential upside of approximately 37.5% from the last closing price of $16.00 on March, 2024. Even if you are not interested in AVDL stock, you should still be aware of its competitors.
37.50% Upside
Avadel Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Avadel Pharmaceuticals's Price has increased by 100.00%, going from $0.00 to $0.00. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach $17.18 – an increase of 100.00%. The Avadel Pharmaceuticals forecast is for Fair Value to reach $29.38 or grow by 100.00%.
Avadel Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030
In the last year, Avadel Pharmaceuticals's Revenue has increased by 25.21%, going from $22.33M to $27.96M. In the next year, analysts are expecting an increase in Revenue, predicting it will reach $142.87M – an increase of 410.98%. The Avadel Pharmaceuticals forecast is for Revenue to reach $437.37M or grow by 1464.27%.
Avadel Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Avadel Pharmaceuticals's EBITDA has grown, increasing from $-34.97M to $-136.08M – a growth of 289.13%. In the following year, 1 experts forecast Avadel Pharmaceuticals's EBITDA will decrease by 109.30%, to $12.65M. In 2030, professionals predict that Avadel Pharmaceuticals's EBITDA will decrease by 1012.53%, to $1.24B.
Avadel Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Avadel Pharmaceuticals's EBIT has grown by 276.02%, from $-36.66M to $-137.85M. According to 7 major analysts, Avadel Pharmaceuticals's EBIT will fall by 72.62% in the next year, reaching $-37.74M. Professionals believe that By 2030, Avadel Pharmaceuticals's EBIT will fall to $291.00M– a 311.10% decrease from its current value.
Avadel Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Avadel Pharmaceuticals's EPS has increased by 100.00%, going from $-0.66 to $0.00. In the next year, analysts are expecting an increase in EPS, predicting it will reach $-0.34 – an increase of 100.00%. The Avadel Pharmaceuticals forecast is for EPS to reach $1.91 or grow by 100.00%.